Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TNFRSF8 positive
i
Other names:
TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
943
Related biomarkers:
Expression
Others
‹
›
Associations
(16)
News
Trials
Search handles
@AaronGoodman33
@DahliaSano
@lingarajnayak
@smbenlazar
Search handles
@AaronGoodman33
@DahliaSano
@lingarajnayak
@smbenlazar
Filter by
Latest
1year
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas https://t.co/INmcZEeAZg #lymsm (@smbenlazar)
1 year ago
Clinical • Combination therapy
|
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Rituxan (rituximab) • doxorubicin hydrochloride • cyclophosphamide • Adcetris (brentuximab vedotin)
over1year
CD30 positive in a elderly DLBCL- Could be EBV associated DLbCl(can do a EBERIH). Can use Brentuximab in this scenario if not fit for savage chemotherapy in view of age or PS. (@lingarajnayak)
over 1 year ago
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Adcetris (brentuximab vedotin)
almost2years
I had a similar patient with sezary syndrome, used mogalizumab to get to CR pre alloSCT. Doing ok 3 yrs post transplant. Can also use Brentuximab if cd30 positive. (@PallawiTorkaMD)
almost 2 years ago
Clinical
|
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Adcetris (brentuximab vedotin)
2years
To transplant or not, that is the question! 50 year old with CD30 positive angioimmunoblastic T-cell lymphoma (stage 3, IPI 3) in complete remission after 6 cycles of of brentuximab+CHP. Good performance status. MUD available. You recommend??? (@AaronGoodman33)
2 years ago
Clinical
|
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Adcetris (brentuximab vedotin)
almost3years
Updates in CD30-Positive Lymphomas https://t.co/BVrhfZCDs1 via @MedscapeCME (@Spanishcountry)
almost 3 years ago
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
3years
Is the patient CD30 positive? There are some data about brentuximab in PB lymphoma. (@DahliaSano)
3 years ago
Clinical
|
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Adcetris (brentuximab vedotin)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login